Goldstein David M - Principia Biopharma

基本信息

浏览量：15

职业迁徙

个人简介

暂无内容

研究兴趣

论文共 101 篇作者统计合作学者相似作者

按年份排序按引用量排序主题筛选期刊级别筛选合作者筛选合作机构筛选

Supplementary Table and Supplementary Figures 1-2 from the Irreversible Covalent Fibroblast Growth Factor Receptor Inhibitor PRN1371 Exhibits Sustained Inhibition of FGFR after Drug Clearance

Eleni Venetsanakos,Ken A. Brameld,Vernon T. Phan,Erik Verner,Timothy D. Owens, Yan Xing,Danny Tam,Jacob LaStant,Kwan Leung,Dane E. Karr, Ronald J. Hill, Mary E. Gerritsen,David M. Goldstein,Jens Oliver Funk, J. Michael Bradshaw

openalex（2023）

引用0浏览0引用

Preclinical Efficacy and Anti-Inflammatory Mechanisms of Action of the Bruton Tyrosine Kinase Inhibitor Rilzabrutinib for Immune-Mediated Disease

Claire L. Langrish,J. Michael Bradshaw,Michelle R. Francesco,Timothy D. Owens,Yan Xing,Jin Shu,Jacob LaStant,Angelina Bisconte,Catherine Outerbridge,Stephen D. White,Ronald J. Hill,Ken A. Brameld,David M. Goldstein,Philip A. Nunn

JOURNAL OF IMMUNOLOGY（2021）

引用64浏览0WOS引用

Preclinical Mechanisms of Topical PRN473, a Bruton Tyrosine Kinase Inhibitor, in Immune-Mediated Skin Disease Models

Yan Xing,Katherine A Chu, Jyoti Wadhwa, Wei Chen,Jiang Zhu,J Michael Bradshaw,Jin Shu, Matthew C Foulke,Natalie Loewenstein,Philip Nunn,Kolbot By,Pasit Phiasivongsa,David M Goldstein,Claire L Langrish

ImmunoHorizons（2021）

引用13浏览0WOS引用

Method of Levels Therapy

Warren Mansell,David M. Goldstein

The Interdisciplinary Handbook of Perceptual Control Theorypp.503-515, (2020)

引用1浏览0引用

The Irreversible Covalent Fibroblast Growth Factor Receptor Inhibitor PRN1371 Exhibits Sustained Inhibition of FGFR after Drug Clearance

Eleni Venetsanakos,Ken A. Brameld,Vernon T. Phan,Erik Verner,Timothy D. Owens,Yan Xing,Danny Tam,Jacob LaStant,Kwan Leung,Dane E. Karr,Ronald J. Hill,Mary E. Gerritsen,David M. Goldstein,Jens Oliver Funk,J. Michael Bradshaw

Molecular Cancer Therapeutics（2017）

引用23浏览0WOS引用

PRN1371, an Irreversible, Covalent Inhibitor of FGFR1-4 Exhibits Sustained Pathway Inhibition in Cancer Cell Lines

Eleni Venetsanakos,Yan Xing,Natalie Loewenstein,J. Michael Bradshaw,Dane Karr,Jacob LaStant,Philip Nunn,Jin Shu, Abha Bommireddi,Jens Oliver Funk,David M. Goldstein, Stefani Wolff,Ken A. Brameld,Steven G. Gourlay

CANCER RESEARCH（2017）

引用0浏览0引用

Discovery of the Irreversible Covalent FGFR Inhibitor 8-(3-(4-acryloylpiperazin-1-yl)propyl)-6-(2,6-dichloro-3,5-dimethoxyphenyl)-2-(methylamino)pyrido[2,3-d]pyrimidin-7(8h)-one (PRN1371) for the Treatment of Solid Tumors

Ken A. Brameld,Timothy D. Owens,Erik Verner,Eleni Venetsanakos,J. Michael Bradshaw,Vernon T. Phan,Danny Tam,Kwan Leung,Jin Shu,Jacob LaStant, David G. Loughhead,Tony Ton,Dane E. Karr,Mary E. Gerritsen,David M. Goldstein,Jens Oliver Funk

Journal of Medicinal Chemistry（2017）

引用85浏览0WOS引用

Mitigation of Reactive Metabolite Formation for a Series of 3-Amino-2-pyridone Inhibitors of Bruton’s Tyrosine Kinase (BTK)

Yan Lou,Francisco Lopez, Yongying Jiang,Xiaochun Han, Chris Brotherton,Roland Billedeau,Steve Gabriel, Shelly Gleason,David M. Goldstein,Ramona Hilgenkamp,Buelent Kocer,Lucja Orzechowski,Jenny Tan,Peter Wovkulich,Bo Wen,David Fry,Paola Di Lello, Lucy Chen,Fang-jie Zhang,Jennifer Fretland, Anjali Nangia,Tian Yang,Timothy D. Owens

Bioorganic & Medicinal Chemistry Letters（2016）

引用9浏览0WOS引用

Prn1371, an Irreversible, Covalent Inhibitor of Fgfr1, 2, 3 and 4 is Highly Efficacious in Preclinical Tumor Models

Eleni Venetsanakos,Michael Bradshaw,David M. Goldstein,Kwan Leung,Dane Karr,Yan Xing,Jacob LaStant,Philip Nunn,Jin Shu, Abha Bommireddi,Steven G. Gourlay,Jens Oliver Funk,Ken A. Brameld

CANCER RESEARCH（2016）

引用0浏览0引用

加载更多

作者统计

合作学者

合作机构

D-Core

合作者
学生
导师

暂无相似学者，你可以通过学者研究领域进行搜索筛选

数据免责声明

页面数据均来自互联网公开来源、合作出版商和通过AI技术自动分析结果，我们不对页面数据的有效性、准确性、正确性、可靠性、完整性和及时性做出任何承诺和保证。若有疑问，可以通过电子邮件方式联系我们：report@aminer.cn